Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Divi's Laboratories (DIVI IN)
Watchlist
125
Analysis
Health Care
•
India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Bharat Heavy Electricals
•
26 Aug 2024 05:50
NIFTY NEXT50 Index Rebalance: 7 Changes on Expected Lines
There are 7 changes for the NIFTY Next50 Index. Estimated 1-way turnover is 19.6% resulting in a 1-way trade of INR 63.64bn (US$759m). There are...
Brian Freitas
Follow
851 Views
Share
bullish
•
Trent
•
25 Aug 2024 08:00
NIFTY50 Index Rebalance: Trent, BEL to Replace Divi's Lab, LTIMindtree
Trent and Bharat Electronics will replace LTIM and Divi Lab in the NIFTY50. There is over 5x ADV/11x delivery volume to trade in the stocks. There...
Brian Freitas
Follow
715 Views
Share
bullish
•
Dr. Reddy's Laboratories
•
20 Aug 2024 16:42
Quiddity Leaderboard NIFTY Sep 24: Final Expectations; Trades Perform Positively; New Ideas
The official index changes for the NIFTY September 2024 index rebal event will be confirmed after market close on Friday 23rd August 2024. In this...
Janaghan Jeyakumar, CFA
Follow
887 Views
Share
bullish
•
Akums Drugs and Pharmaceuticals
•
05 Aug 2024 15:30
Akums Drugs and Pharmaceuticals IPO Trading - Strong Demand and a Decent Margin of Safety
Akums Drugs and Pharmaceuticals (0200361D IN) raised around US$222m in its India IPO, after pricing the deal at the top end of the range at INR679...
Ethan Aw
405 Views
Share
bullish
•
HDFC Bank
•
30 Jul 2024 15:32
India: Potential Free Float Changes & Passive Flows in August
Changes to shareholding patterns could lead to changes in float for some stocks in local/global indices. Passive trackers will need to trade over 4...
Brian Freitas
Follow
758 Views
Share
First
Previous
14
15
16
17
18
19
20
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x